SCHEMBL7680503

SCHEMBL7680503

COc1cccc(C(C)(C)C(=O)ON=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
STAT1 P42224 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
TP53 P04637 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3507981 0.84 NPC1 (0.49) PARP1CES2CES1NPC1RAB9A
SCHEMBL18231508 0.81 MAPT (0.56) PARP1CES2CES1NPC1RAB9A
SCHEMBL1356271 0.79 AKR1C3 (0.52) PARP1CES2CES1NPC1RAB9A
SCHEMBL1546686 0.79 CES2 (0.50) PARP1CES2CES1NPC1RAB9A
SCHEMBL3928629 0.79 CNR2 (0.50) CES2CES1NPC1RAB9ALMNA
SCHEMBL6671614 0.76 CES2 (0.47) PARP1CES2CES1NPC1RAB9A
SCHEMBL25460833 0.75 NPC1 (0.47) PARP1CES2CES1NPC1RAB9A
SCHEMBL27403227 0.74 MAOB (0.50) NPC1RAB9AMAPTSMN1; SMN2L3MBTL1
SCHEMBL13178117 0.74 NPC1 (0.49) PARP1CES2CES1NPC1RAB9A
SCHEMBL6273920 0.74 CES2 (0.44) PARP1CES2CES1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358974-B1 USED AS AS MODULATORS OF DOPAMINE D.SUB.3 RECEPTORS, IN THERAPY AS ANTIPSYCHOTIC AGENTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-03-19 US disclosed